Barik Braja Sundar, Kar Chinmay Divyadarshi, Das Shritam, Hussain Tahziba, Nayak Sasmita, Sahu Arun Kumar, Sundaray Sooman, Pati Sanghamitra
Division of NCDs, ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
Department of Biotechnology, School of Biotechnology, KIIT University, Bhubaneswar, Odisha, India.
J Glob Infect Dis. 2025 Mar 31;17(1):52-59. doi: 10.4103/jgid.jgid_78_24. eCollection 2025 Jan-Mar.
Contacts of tuberculosis (TB) patients have an increased risk of latent TB infection (LTBI). Currently, it is diagnosed using one of the two methods: Tuberculin skin test (TST) or QuantiFERON-TB Gold Plus. This study aims to estimate the concordance of TST and QFT-TB Gold Plus and associated factors among 73 healthcare workers (HCWs) and 172 household contacts (HHCs) who came in contact with active TB patients. This study was conducted from January to June 2023.
Prevalence and agreement were calculated. A regression analysis was performed to assess the predictors of discordance factors.
The prevalence of latent TB was 20.40% ( = 50), defined as a positive result on either test. The overall agreement among participants was 62.04%, with a kappa coefficient of 0.26 (0.16-0.36, 95% confidence interval [CI]) (McNemar, < 0.001). A higher risk of LTBI was associated with BCG vaccination history, odd ratio 1.63, (95% CI 0.78-3.43) for TST and 0.51 (95% CI 0.22-1.15) for QFT, but this was not significant. Moreover, in our study, only the body mass index of 18.5-25 kg/m yielded an odds ratio of 2.33 (95%CI 0.77-6.47) for TST and 1.72 (95% CI 0.48-6.05) for QFT, was significant. Compared with QFT-TB Gold Plus, the sensitivity and specificity of TST were 80.65 (68.63-89.58) and 55.74 (48.22-63.06).
TST exhibited a profound level of agreement with the QFT-Gold Plus assay but showed a higher rate of positivity due to some associated factors among HCWs, HHCs, and TB patients.
结核病(TB)患者的接触者发生潜伏性结核感染(LTBI)的风险增加。目前,采用两种方法之一进行诊断:结核菌素皮肤试验(TST)或QuantiFERON-TB Gold Plus。本研究旨在评估73名医护人员(HCWs)和172名家庭接触者(HHCs)与活动性结核病患者接触后TST和QFT-TB Gold Plus的一致性及相关因素。本研究于2023年1月至6月进行。
计算患病率和一致性。进行回归分析以评估不一致因素的预测指标。
潜伏性结核的患病率为20.40%(n = 50),定义为两种检测中任一种结果为阳性。参与者之间的总体一致性为62.04%,kappa系数为0.26(0.16 - 0.36,95%置信区间[CI])(McNemar检验,P < 0.001)。LTBI的较高风险与卡介苗接种史相关,TST的比值比为1.63(95% CI 0.78 - 3.43),QFT的比值比为0.51(95% CI 0.22 - 1.15),但差异无统计学意义。此外,在我们的研究中,仅体重指数为18.5 - 25 kg/m²时,TST的比值比为2.33(95%CI 0.77 - 6.47),QFT的比值比为1.72(95% CI 0.48 - 6.05),具有统计学意义。与QFT-TB Gold Plus相比,TST的敏感性和特异性分别为80.65(68.63 - 89.58)和55.74(48.22 - 63.06)。
TST与QFT-Gold Plus检测表现出一定程度的一致性,但由于医护人员、家庭接触者和结核病患者中的一些相关因素,TST显示出更高阳性率。